Tympanogen
PrivateLast Round
Series A
Jul 30, 2025
Total Funding Raised
$6.27M
Company Overview
Tympanogen, Inc. is a medical device company that develops, manufactures, and markets products for the ear, nose, and throat (ENT) sector. The company's flagship product is Perf-Fix™, a gel patch designed for the nonsurgical repair of perforated eardrums. This technology aims to replace traditional, invasive tympanoplasty surgeries with a quick, in-office procedure. Founded in 2014, the company is based in Richmond, Virginia, and operates out of the VA Bio+Tech Park. As of mid-2025, Tympanogen is actively raising capital to support the commercial launch of Perf-Fix, which is expected in 2026. The company has received significant non-dilutive grant funding from institutions like the National Institutes of Health and the Department of Defense, and has also conducted research aboard the International Space Station.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tympanogen Comps
Public and private peers based on sector, stage, and business model.
Tympanogen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 30, 2025 | ||||
| Grant | Jul 25, 2023 | ||||
| Grant | Nov 1, 2021 | ||||
| Grant | Jun 17, 2020 | ||||
| Grant | Jan 7, 2020 | ||||
Grant | Nov 18, 2019 |
Tympanogen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| CAV Angels | Series A |
| Virginia Innovation Partnership Corporation | Seed |
| Keiretsu Forum Mid-Atlantic | Series A |
| National Institute on Deafness and Other Communication Disorders | Grant |
| Virginia Catalyst | Grant |
Tympanogen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tympanogen's valuation, stock price, and market status.
